A
ArriVent BioPharma, Inc. (AVBP)
NGM – Real Time Price. Currency in USD
28.97
-0.05 (-0.17%)
At close: May 12, 2026, 4:00 PM EDT
29.00
+0.03 (0.10%)
Pre-market: May 13, 2026, 5:29 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
28.97
-0.05 (-0.17%)
At close: May 12, 2026, 4:00 PM EDT
29.00
+0.03 (0.10%)
Pre-market: May 13, 2026, 5:29 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 12.83 | 6.05 | 10 | |
| Quick ratio | 12.83 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -37M | -75M | -94M | -178M | -178M |
| Net Income | -37M | -69M | -80M | -166M | -166M |
| EBITDA | -37M | -75M | -94M | -178M | -178M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 52.89 | 5.5 |
| Next quarter | N/A | -1.88 | 1.0 |
| Current year | N/A | 13.06 | 4.5 |
| Next year | N/A | 15.44 | 5.0 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -1.61 | -1.15 | 14.36 | 5.0 |
| Y/Y | 999 | -72.26 | -39.93 | -89.8 | 3.3 |
| 3y average | 999 | -70.17 | 11.68 | -60.79 | 4.8 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $45.5M significantly exceed its total debt $14.0K, ensuring strong financial flexibility
Total current assets $332.9M exceed Total current liabilities $25.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$30.7M limits the company's ability to reinvest or pay down debt